about
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody produ...
Read More
15.87
0.29
(1.86%)
628.2K
XNAS Volume
XNAS 21 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Xencor Inc is on 02 Dec 2025 for the purpose of Piper Sandler 37th Annual Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Xencor Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..